General Genetics Corporation provides genetic, clinical, and forensic laboratory services. It provides forensic testing services in the areas of DNA paternity testing, DNA predisposition testing, ancestral origins DNA ancestry testing, infidelity DNA testing, DNA maternity testing, siblingship SNA testing, twin zygosity DNA testing, grandparent/aunt/uncle DNA testing, missing parent DNA testing, immigration DNA testing, prenatal paternity testing, and Y-STR male lineage DNA testing. The company also provides clinical testing services in the areas of predisposition testing for immune systems, cardiovascular conditions, aging, and cancers; and plavix testing for preventing clot-related events,...
MSC3ARP, Box 30001
3655 Research Drive
Las Cruces, NM 88003
General Genetics Corporation Announces Management Changes
Aug 20 13
General Genetics Corporation announced its has expanded the board of directors, the joining board members were Rayburn Thompson, Thomas J. Ridge, Dr. Arthur B. Laffer, Stefano Ciampolini. Mr. Thompson is the Chief Executive Officer of General Genetics Corporation (GGC) and has been in healthcare executive management positions for nearly 30 years. Prior to becoming CEO of GGC, he was the Chief Administrative Officer for Solstas Lab Partners. Mr. Ridge is the CEO of Ridge Global. Mr. Ridge was the first Assistant to the President for Homeland Security and on January 24, 2003, was appointed the first Secretary of the U.S. Department of Homeland Security. Dr. Laffer is the founder and Chairman of Laffer Associates, an economic research and consulting firm that provides global investment-research services to institutional asset managers, pension funds, financial institutions and corporations. Dr. Laffer is a founding member. Mr. Ciampolini is Adjunct Professor of Imperial College Business School in London and co-founder of Healthcare Capital Partners, a London based private equity and corporate finance advisory boutique specialized in life sciences and healthcare ventures. R. James Bentley, Executive Vice President of North American Business Development. A chemist by training, Mr. Bentley has spent his over 30-year career in technical operations and sales roles for various laboratories. Prior to Bode he was in business development, consulting and general management positions for a variety of other laboratory, industrial hygiene and environmental management companies. Kevin Camilleri, Chief Operating Officer International Division Mr. Camilleri is an entrepreneur and co-founder of EasyDNA. As President of EasyDNA. He started his career in the Business Advisory Division of PriceWaterhouseCoopers. Kelly Bewick, Chief Financial Officer Ms. Bewick held several corporate controller positions, including most recently for a manufacturer of synthetic DNA called Intrexon. Ms. Bewick was also director of financial analysis and compliance for Luna Innovations.